High-sensitivity C-reactive protein (hs-CRP) in systemic lupus erythematosus patients without cardiac involvement; relation to disease activity, damage and intima-media thickness-Reference-Cited by-同舟云学术

High-sensitivity C-reactive protein (hs-CRP) in systemic lupus erythematosus patients without cardiac involvement; relation to disease activity, damage and intima-media thickness

Published:2012-10 Issue:4 Volume:34 Page:147-152
ISSN:1110-1164
Container-title:The Egyptian Rheumatologist
language:en
Short-container-title:The Egyptian Rheumatologist

Author:

Gheita Tamer A.,El-Gazzar Iman I.,Azkalany Ghada,El-Fishawy Hussein S.,El-Faramawy Amr

Publisher

Elsevier BV

Subject

Rheumatology

Reference42 articles.

1. Towards the Swiss systemic lupus erythematosus cohort study (SSCS);Chizzolini;Rev Med Suisse,2009

2. Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus;Doria;Ann Rheum Dis,2003

3. Novel cardiovascular risk factors in premature coronary atherosclerosis associated with systemic lupus erythematosus;Rho;J Rheumatol,2008

4. The significance of cardiovascular risk factors and C-reactive protein to the development of atherosclerosis in women with systemic lupus erythematosus;Panafidina;Klin Med (Mosk),2006

5. Thompson D, Bird HA. Acute phase response. In: Isenberg DA, Maddison PJ, Woo P, Glass D, Breedveld FC, editors. Oxford textbook of Rheumatology, 3rd ed. Oxford, 2004, p. 475.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. C-reactive protein: structure, function, regulation, and role in clinical diseases;Frontiers in Immunology;2024-06-14

2. Changes in Gut Microbiota and Systemic Inflammation after Synbiotic Supplementation in Patients with Systemic Lupus Erythematosus: A Randomized, Double-Blind, Placebo-Controlled Trial;Cells;2022-10-29

3. Outcome of total hip arthroplasty for avascular necrosis of femoral head in systemic lupus erythematosus patients: A comparative study;The Egyptian Rheumatologist;2022-06

4. Total Glucosides of Paeonia lactiflora for Safely Reducing Disease Activity in Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis;Frontiers in Pharmacology;2022-01-31

5. Predictors of admission to intensive care unit among systemic lupus erythematosus patients: prospective study;Egyptian Rheumatology and Rehabilitation;2022-01-11